ArrowMark Colorado Holdings’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-786,664
Closed -$17M 334
2022
Q4
$17M Sell
786,664
-4,585
-0.6% -$96.9K 0.2% 99
2022
Q3
$15.3M Buy
791,249
+184,286
+30% +$3.81M 0.19% 111
2022
Q2
$12.1M Sell
606,963
-33,930
-5% -$895K 0.14% 139
2022
Q1
$19.1M Buy
640,893
+4,547
+0.7% +$133K 0.17% 123
2021
Q4
$14.8M Buy
636,346
+6,769
+1% +$180K 0.12% 147
2021
Q3
$19.6M Sell
629,577
-52,424
-8% -$1.62M 0.15% 128
2021
Q2
$24M Sell
682,001
-16,746
-2% -$544K 0.18% 120
2021
Q1
$24.6M Sell
698,747
-52,748
-7% -$1.95M 0.18% 118
2020
Q4
$28.2M Sell
751,495
-47,069
-6% -$1.71M 0.22% 106
2020
Q3
$26.6M Sell
798,564
-158,426
-17% -$4.61M 0.25% 92
2020
Q2
$25.4M Sell
956,990
-15,382
-2% -$363K 0.26% 89
2020
Q1
$15.9M Buy
972,372
+105,322
+12% +$2.32M 0.21% 99
2019
Q4
$22M Buy
867,050
+243,670
+39% +$4.87M 0.2% 105
2019
Q3
$12.5M Buy
623,380
+67,652
+12% +$1.75M 0.12% 139
2019
Q2
$17.9M Sell
555,728
-104,714
-16% -$3.5M 0.17% 116
2019
Q1
$21.3M Buy
660,442
+48,450
+8% +$1.3M 0.2% 107
2018
Q4
$15M Buy
611,992
+55,925
+10% +$1.48M 0.16% 127
2018
Q3
$18.3M Buy
556,067
+42,818
+8% +$1.4M 0.16% 131
2018
Q2
$18.2M Buy
513,249
+107,897
+27% +$3.49M 0.17% 127
2018
Q1
$13.2M Buy
+405,352
New +$13.6M 0.14% 152

Other funds holding ALBO